Groowe Groowe / Newsroom / EXEL
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

EXEL News

Exelixis Inc

Handa Oncology Receives FDA Final Approval for OMCAZIO(TM) (cabozantinib) Capsules

accessnewswire.com
EXEL

Form 8-K

sec.gov
EXEL

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

globenewswire.com
ADAG EXEL

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight

globenewswire.com
TLRY TAK TNDM NVS BMY PFE INCY JNJ AZN MRK ABBV CRSP SCLX RIGL JAZZ GILD REGN AMGN BIIB PTGX EXAS SNOW SRPT VRTX BNTX ALKS RGEN IMUX ADPT ATRC CRNX CYTK DTIL EXEL FGEN GALT GNTX GRFS GSK HRMY IDXX ILMN INSM IONS IRWD KODK LAKE LULU LYFT MAR MDLZ MELI MIRM MNKD MRNA MTCH NBIX NCLH NEM NTRA NVCR ODFL OMER ORGO OTEX PACB PBYI PCAR PEGA PERI PETS PLRX PMVP PPC PRGS PRTA PSNL PTN PZZA QGEN QTRX RARE RCEL RDHL RLAY RLGT RMD ROST RRX RYAAY RYTM SAN SBAC SBRA SEIC SIGA SIRI SITE SLAB SLGN SMCI SMMT SNPS SNY SOFI SONO SPCE SSYS STNG STRA STRL STX SWKS SYK SYNA TCOM TDOC TECK TEVA TFX TGTX TIGR TRMB TRVG TTWO TUSK TXRH ULTA UMC UNFI UNH URBN UTHR VEEV VELO VERU VIVO VKTX VLRS VNDA VRSK VSAT VTGN WDC WEC WERN WGO WIX WMB WST WTW WYNN XOM XPER XPO XRAY YETI YRD YUM ZBRA ZLAB ZYME

Caring Men Global Announces Rollout and Fall Program Expansion of Strong Caregivers, Stronger Survivors

businesswire.com
EXEL NVS

Chondrosarcoma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

globenewswire.com
INBX LLY PFE NVS BMY EXEL JNJ AZN JAZZ TLRY

Form 8-K

sec.gov
EXEL

Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories

businesswire.com
EXEL

Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider

globenewswire.com
PFE LLY MRK GILD ABBV BMY AMGN PBYI GSK TEVA EXEL

AI-Driven Modular Microfactories Emerge as a Global Manufacturing Frontier, Backed by Record Investment and Government Policy Mandates

globenewswire.com
RBLX MSFT GOOG AMZN NVDA INTC AMD IBM RCL VLN PATH APPN VNDA RVSN EXEL STLA NSSC SES